首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   85篇
  免费   6篇
化学   69篇
晶体学   1篇
力学   1篇
数学   8篇
物理学   12篇
  2022年   1篇
  2021年   2篇
  2020年   2篇
  2019年   3篇
  2018年   1篇
  2017年   2篇
  2016年   5篇
  2015年   6篇
  2014年   6篇
  2013年   6篇
  2012年   5篇
  2011年   5篇
  2010年   3篇
  2008年   11篇
  2007年   3篇
  2006年   5篇
  2005年   3篇
  2004年   1篇
  2002年   1篇
  2001年   1篇
  1997年   1篇
  1990年   2篇
  1987年   1篇
  1986年   1篇
  1985年   1篇
  1983年   1篇
  1982年   3篇
  1981年   2篇
  1980年   1篇
  1979年   1篇
  1977年   2篇
  1970年   2篇
  1969年   1篇
排序方式: 共有91条查询结果,搜索用时 15 毫秒
11.
The proposed study examined the preparation of chitosan (CS)–polyvinylpyrrolidone (PVP)–bovine serum albumin (BSA)-coated magnetic iron oxide (Fe3O4) nanoparticles (Fe3O4–CS–PVP–BSA) to use as potential drug delivery carriers for delivery of tamoxifen drug (TAM) . The anticancer drug selected in this study was tamoxifen which can be used for the human breast cancer treatment. These prepared nanoparticles were characterized by FTIR, XRD, SEM, AFM, TEM, CD and VSM techniques. The swelling studies have been measured at different (10, 20, 30, 40, 50%) drug loading. The mean particle size of the tamoxifen-loaded nanoparticles system (Fe3O4–CS–TAM, Fe3O4–CS–TAM–PVP and Fe3O4–CS–TAM–PVP–BSA) as measured by Malvern Zetasizer ranged between 350 ± 2.3 and 601 ± 1.7 nm. As well as these drug-loaded nanoparticles were positively charged. The zeta potential was in the range of 28.9 ± 3.5 and 50.8 ± 3.9 mV. The encapsulation efficiency was between 63.60 ± 2.11 and 96.45 ± 2.12%. Furthermore, in vitro release and drug loading efficiency from the nanoparticles were investigated. The cytotoxicity of prepared nanoparticles was verified by MTT assay. In vitro release studies were executed in 4.0 and 7.4 pH media to simulate the intestinal and gastric conditions and different temperature (37 and 42 °C). Hence, the prepared tamoxifen-loaded nanoparticles system (Fe3O4–CS–TAM, Fe3O4–CS–TAM–PVP and Fe3O4–CS–TAM–PVP–BSA) could be a promising candidate in cancer therapy.  相似文献   
12.
Multi-reference M?ller-Plesset calculations of a model of the Ni-SI state of nickel-iron hydrogenase predict a singlet rather than a triplet state for this species, and show that it is better described with a BP86 rather than a B3LYP functional.  相似文献   
13.
Experimental data suggest that there are various competing pathways for the catalytic and stoichiometric oxygenation of cyclohexane, assisted by iron-bispidine complexes and using various oxidants (H(2)O(2), O(2), PhIO). Density functional theory calculations indicate that both Fe(IV)=O and Fe(V)=O species are accessible and efficiently transfer their oxygen atoms to cyclohexane. The reactivities of the two isomers each and the two possible spin states for the Fe(IV)=O and Fe(V)=O species are sufficiently different to allow an interpretation of the experimental data.  相似文献   
14.
Bioligninolysis involves living organisms and/or their products in degradation of lignin, which is highly resistant, plant-originated polymer having three-dimensional network of dimethoxylated (syringyl), monomethoxylated (guaiacyl), and non-methoxylated (p-hydroxyphenyl) phenylpropanoid and acetylated units. As a major repository of aromatic chemical structures on earth, lignin bears paramount significance for its removal owing to potential application of bioligninolytic systems in industrial production. Early reports illustrating the discovery and cloning of ligninolytic biocatalysts in fungi was truly a landmark in the field of enzymatic delignification. However, the enzymology for bacterial delignification is hitherto poorly understood. Moreover, the lignin-degrading bacterial genes are still unknown and need further exploration. This review deals with the current knowledge about ligninolytic enzyme families produced by fungi and bacteria, their mechanisms of action, and genetic regulation and reservations, which render them attractive candidates in biotechnological applications.  相似文献   
15.
Two synthetic derivatives of the naturally occurring cyclic pseudooctapeptides patellamide A–F and ascidiacyclamide, that is, H4pat2, H4pat3, as well as their CuII complexes are described. These cyclic peptide derivatives differ from the naturally occurring macrocycles by the variation of the incorporated heterocyclic donor groups and the configuration of the amino acids connecting the heterocycles. The exchange of the oxazoline and thiazole groups by dimethylimidazoles or methyloxazoles leads to more rigid macrocycles, and the changes in the configuration of the side chains leads to significant differences in the folding of the cyclic peptides. These variations allow a detailed study of the various possible structural changes on the chemistry of the CuII complexes formed. The coordination of CuII with these macrocyclic species was monitored by high‐resolution electrospray mass spectrometry (ESI‐MS), spectrophotometric (UV/Vis) and circular dichroic (CD) titrations, and electron paramagnetic resonance (EPR) spectroscopy. Density functional theory (DFT) calculations and molecular mechanics (MM) simulations have been used to model the structures of the CuII complexes and provide a detailed understanding of their geometric preferences and conformational flexibility. This is related to the CuII coordination chemistry and the reactivity of the dinuclear CuII complexes towards CO2 fixation. The variation observed between the natural and various synthetic peptide systems enables conclusions about structure–reactivity correlations, and our results also provide information on why nature might have chosen oxazolines and thiazoles as incorporated heterocycles.  相似文献   
16.
17.
A concise, scaleable synthesis of building block 10 for p38 kinase inhibitor B is described. The key step is the one-pot construction of 5-aryl-3-methyl-2-methylsulfanyl-6-pyridin-4-yl-3H-pyrimidin-4-one 4 from arylacetic acid ethyl ester 1. Subsequent hydrolysis of the thiomethyl group to the hydroxy group and chlorination provided the key intermediate, 2-chloro-3-methyl-6-pyridin-4-yl-5-aryl-3H-pyrimidin-4-one 10. This class of reactive building blocks enabled the rapid evaluation of a variety of side chains at the 2-position of the pyrimidinone in SAR studies of inhibitors of p38 MAP kinase.  相似文献   
18.
We have explored possible mechanisms for the formation of the catalytically active Ni(a)-S state of the enzyme, nickel iron hydrogenase, from the Ni*(r) (ready) or Ni*(u) (unready) state, by reaction with H(2), using density functional theory calculations with the BP86 functional in conjunction with a DZVP basis set. We find that for the reaction of the ready state, which is taken to have an -OH bridge, the rate determining step is the cleavage of H(2) at the Ni(3+) centre with a barrier of approximately 15 kcal mol(-1). We take the unready state to have a -OOH bridge, and find that reaction with H(2) to form the Ni(r)-S state can proceed by two possible routes. One such path has a number of steps involving electron transfer, which is consistent with experiment, as is the calculated barrier of approximately 19 kcal mol(-1). The alternative pathway, with a lower barrier, may not be rate determining. Overall, our predictions give barriers in line with experiment, and allow details of the mechanism to be explored which are inaccessible from experiment.  相似文献   
19.
20.
The behavior of the chelate, ferric dipivaloylmethide, Fe(DPM)3, in vinyl polymerization systems was investigated. The polymerization was found to be of free-radical nature. The rate of polymerization was proportional to the square root of the concentration of the chelate. The monomer exponent was close to 1.5 for the Fe(DPM)3-initiated polymerization of styrene and methyl methacrylate. The kinetic and transfer constants and activation energies for these systems have been evaluated. Spectral studies revealed the possibility of a complex formation between the chelate and the monomer. A kinetic scheme for the Fe(DPM)3-initiated polymerization is derived based on this initial complex formation.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号